Hydroxyurea

CAS No. 127-07-1

Hydroxyurea ( NCI C04831; NSC 32065 )

Catalog No. M11135 CAS No. 127-07-1

Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 41 In Stock
1G 48 In Stock

Biological Information

  • Product Name
    Hydroxyurea
  • Note
    Research use only, not for human use.
  • Brief Description
    Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
  • Description
    Hydroxyurea is an antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase.
  • Synonyms
    NCI C04831; NSC 32065
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    DNA/RNA Synthesis
  • Recptor
    ribonucleoside diphosphate reductase
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    127-07-1
  • Formula Weight
    76.06
  • Molecular Formula
    CH4N2O2
  • Purity
    >98%(HPLC)
  • Solubility
    Water: 15 mg/mL (197.23 mM); DMSO: 15 mg/mL (197.23 mM)
  • SMILES
    O=C(N)NO
  • Chemical Name
    1-hydroxyurea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Culligan K, et al. Plant Cell. 2004 May;16(5):1091-104.
molnova catalog
related products
  • Asimadoline

    Asimadoline is a proprietary small molecule therapeutic, originally developed to treat peripheral pain such as arthritis.

  • Bendamustine hydroch...

    Bendamustine hydrochloride is an alkylating agent associated with DNA damage with IC50 of 50 μM.

  • Rifapentine

    Rifapentine is an antibiotic drug used in the treatment of tuberculosis.